Effects of medroxyprogesterone acetate employed as a long-term injectable contraceptive.
D000328:Adult; D001835:Body Weight / Q000187:drug effects; D001940:Breast / Q000166:cytology / Q000187:drug effects / Q000473:pathology; D001943:Breast Neoplasms / Q000473:pathology; D055598:Chemical Phenomena; D002621:Chemistry; D003270:Contraceptive Agents / Q000008:administration & dosage*; D004717:Endometrium / Q000187:drug effects; D005187:Fallopian Tubes / Q000187:drug effects; D005260:Female; D005298:Fertility / Q000187:drug effects; D006801:Humans; D007267:Injections; D008525:Medroxyprogesterone / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D008598:Menstruation / Q000187:drug effects; D010053:Ovary / Q000187:drug effects; D010212:Papilloma / Q000473:pathology; D010298:Parity; D013997:Time Factors; D014621:Vagina / Q000166:cytology; D014626:Vaginal Smears
D003270:Contraceptive Agents; D008525:Medroxyprogesterone